Imugene Ltd advances to higher dosage level in Phase 1 clini

Imugene Ltd (ASX:IMU, OTC:IUGNF) has successfully progressed to the next stage of its Phase 1 clinical trial evaluating the safety of novel cancer-killing...

Related Keywords

Australia , United States , Leslie Chong , Imugene Ltd , Cohort Review Committee ,